Octadecyl methacrylate

We are Octadecyl methacrylate CAS:32360-05-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Octadecyl methacrylate
CAS.NO:32360-05-7
Synonyms:Octadecyl methacrylate
N-STEARYL METHACRYLATE
METHACRYLIC ACID STEARYL ESTER
Stearyl Methylacrylate
octadecylmethacrylate
Molecular Formula:C22H42O2
Molecular Weight:338.56800
 
Physical and Chemical Properties:
Density:0.864
Melting point:18-20ºC
Boiling point:195ºC
Flash point:>230°F
Index of Refraction:1.451
 
Specification:
Appearance:Yellow transparent liquid
Assay:≥99.0%
Chromaticity:≤80 APHA
Moisture:≤0.2%
Acid value:≤0.3
MEHQ:150-250 ppm
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:A kind of long chain alkyl acrylate which enable it’s down stream polymer owns good hydrophobic & oleophylic properties. It could be used for the synthesis of various chemical compound such as crude oil pour point depressant, fabric waterproofing agent & oil proofing agent, waterproofing agent for leather, oil absorption resin. It could also be used for the modification of polymer in the ink, paint and adhesive industries.

Octadecyl methacrylate


Related News: Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,” Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.1- (4-fenil-1H-imidazol-2-il) -etilamina CAS:864825-23-0 Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,” Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.Ácido 2-bromopiridina-4-carboxílico CAS:66572-56-3 Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.8-Bromo-1-octene The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.

Related Products
Product Name
methyl 5-chloro-3-(chlorosulfonyl)-thiophene-2-carboxylate View Details
Antioxidant 5057 View Details
1-Chloro-2-methyl-3-methylsulfanylbenzene View Details
1-butyl-2,3-dimethylimidazolium tetrafluoroborate manufacturer 4-Methylpiperidine manufacturer 1-Bromoheptane manufacturer (2S,3R)-3-Amino-2-hydroxy-4-phenylbutyric acid manufacturer Ethyl 2-ethyl-3-oxobutanoate manufacturer